According to the new market research report,
“Gene Expression Analysis Market by Technology (DNA Microarray, Real-Time
PCR, Next Generation Sequencing), Consumables (DNA Chips, Reagents), Services
(Gene Profiling, Bioinformatics, Data Analysis Software) & Applications -
Global Forecast to 2018 ”, published by MarketsandMarkets, global gene
expression analysis market estimated at $2.6 billion in 2013 and is expected to
reach $4.3 billion by 2018, growing at a CAGR of 10.4% from 2013 to 2018.
Browse 72 market
data tables and 20 figures spread through 227 pages and in-depth TOC on “Gene
Expression Analysis Market”.
Early buyers will receive 10% customization on this report.
The global market
was valued at $2.6 billion in 2013 and is expected to reach $4.3 billion by
2018, at a CAGR of 10.4%. Increasing number of cancer patients, growth in the
number of funding activities, technological advancements, and increased
interest in gene expression for research and discovery are the major factors
driving the growth of this market. Moreover, various government bodies have
extended their help in the form of investments, funds, and grants, which has
further stimulated the growth of the market.
Download Free sample Copy of Report: http://www.marketsandmarkets.com/requestsample.asp?id=156613968
Gene expression analysis has emerged as a major advancement in the fields
of drug discovery, diagnostics, and biomedical research. Since the completion
of the Human Genome Project in 2003, numerous methods are being developed to
improve the efficiency and effectiveness of gene expression profiling and
sequencing. it is an important process, as it enables researchers to
decipher the functions of genes. By sequencing genes, researchers can determine
how diseases affect a cell. Genome-wide analysis can be used to accurately
classify diseases. This has led to its increased use in various applications
such as pharmacogenomics, diagnostics, toxicogenomics, and biomarkers.
This report broadly categorizes the global market into three segments,
namely, instrumentation, consumables, and services. The large share of
consumables is specifically attributed to the wide use of gene expression
analysis techniques in cancer diagnostics. The increase in the number of
genetic tests directly favors volume consumption of consumables. The gene
expression services market is expected to grow at the highest CAGR of XX% from
2013 to 2018. This high growth can be attributed to the growing adoption of
next-generation sequencing, advancements in bioinformatics tools, and the
declining cost of sequencing.
Over the years, gene expression analysis has evolved significantly and is
widely used for the diagnosis and treatment of various disorders like cancer,
Alzheimer’s, and Parkinson’s, among others. In the past few years, the market
has witnessed significant technological advancements, as companies have
introduced newer sequencing and analysis platforms. This has aided in the
diagnosis and treatment of diseases. This report covers the definition,
description, and forecast of the global market in terms of instrumentation,
consumables, services, and applications.
“The global market was valued at $2.6 billion in 2013 and is expected to
reach $4.3 billion by 2018, at a CAGR of 10.4%. Increasing number of cancer
patients, growth in the number of funding activities, technological
advancements, and increased interest in gene expression for research and
discovery are the major factors driving the growth of this market. Moreover,
various government bodies have extended their help in the form of investments, funds,
and grants, which has further stimulated the growth of the market.
Life Technologies (U.S.), QIAGEN N.V. (Netherlands), Illumina, Inc.
(U.S.), Roche Diagnostics (Switzerland), Bio-Rad Laboratories, Inc. (U.S.),
Agilent Technologies (U.S.), Affymetrix, Inc. (U.S.), GE Healthcare (U.K.),
Thermo Fisher Scientific (U.S.), PerkinElmer, Inc. (U.S.), Luminex Corporation
(U.S.), and Oxford Gene Technology, Inc. (U.K.) are some of the prominent
players in the global market.
Browse related reports:
Next Generation Sequencing (NGS) Market
[Platforms (Illumina HiSeq, MiSeq, Life Technologies Ion Proton/PGM, 454
Roche), Bioinformatics (RNA-Seq, ChIP-Seq), (Pyrosequencing, SBS, SMRT),
(Diagnostics, Personalized Medicine)] – Global Forecast to 2017
Genomics Market by Products - [Instruments (NGS
platform, Microarray, RT-PCR), Consumables (Genechips, Reagents for DNA
Extraction & Purification, Sequencing)], Services (Sequencing &
Microarray Services, and Software) - Global Forecast to 2018
About MarketsandMarkets
MarketsandMarkets is a global
market research and consulting company based in the U.S. We publish
strategically analyzed market research reports and serve as a business
intelligence partner to Fortune 500 companies across the world.
MarketsandMarkets also provides
multi-client reports, company profiles, databases, and custom research
services. MarketsandMarkets covers thirteen industry verticals; including
advanced materials, automotive and transportation, banking and financial
services, biotechnology, chemicals, consumer goods, telecommunications and IT,
energy and power, food and beverages, industrial automation, healthcare IT,
medical devices, pharmaceuticals, semiconductor and electronics, aerospace
& defense.
We at MarketsandMarkets are
inspired to help our clients grow by providing apt business insight with our
huge market intelligence repository.
Contact:
Mr. Rohans
North - Dominion Plaza
17304 Preston Road
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Visit MarketsandMarkets Blog @ http://www.marketsandmarketsblog.com/market-reports/healthcare/biotechnology
No comments:
Post a Comment